DiNonA Inc.

The shares were priced at HKD9.10 each. 3SBio offered 484.9 million new shares with further funds being raised by shareholder CITIC Private Equity which offered another 121.2 million shares. 3SBio's d

SEOUL - Biopharma stocks in South Korea have been soaring so far this year with only a brief correction, outpacing gains in the benchmark Kospi and second-tier Kosdaq markets amid a flurry of positive

BEIJING - When an entrepreneur pair set out to start up a biotech firm focusing on the generation and engineering of therapeutic and diagnostic antibodies, they had a vision of marrying an innovative

On the second Monday of each month, “The Pink Sheet” provides exclusive news and commentary on the Asia biopharma market from the editors of our affiliated publication PharmAsia News . BEIJING